This Formerly High-Flying Cryptocurrency Has the Potential to Become the New Bitcoin, According to Tom Lee of Fundstrat

Catalyst Pharmaceuticals (CPRX) offers strong growth, fair valuation, and solid financials, making it a top pick for investors seeking affordable growth in biotech.